How has Mirum Pharmaceuticals, Inc.'s accrued royalties (current) changed year-over-year?

Mirum Pharmaceuticals, Inc.'s accrued royalties (current) increased by 50.9% year-over-year, from $10.09M to $15.22M.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued royalties (current)?

Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued royalties (current) has grown at a 55.3% compound annual growth rate (CAGR), from $6.72M to $16.21M.

Mirum Pharmaceuticals, Inc. MIRM Accrued Royalties (Current)

Accrued Royalties (Current) at other companies

PSK

Paramount Skydance Corporation Class B Common StockPSKY

$2.61B—

InsmedINSM

$162.14M-0.2%

Revolution Medicines, Inc.RVMD

$280.64M—

Take-Two Interactive SoftwareTTWO

$1.12B-0.9%

Lumentum Holdings Inc.LITE

$48.9M+12.4%

Coinbase Global, Inc.COIN

$726.75M+9.8%

Other financials

Income statement

See full

Revenue$159.9M+43.3%

Operating income-$789.5M-5,100%

Net income-$790.2M-5,284%

EPS (diluted)-$13.43-4,377%

Balance sheet

See full

Cash & equivalents$261.5M+43.5%

Total debt$13.5M+56.4%

Total equity$242.5M+4.0%

Total assets$890.9M+29.1%

Cash flow

See full

Operating cash flow-$228.8M-11,566%

CapEx$664.0K+1,520%

Free cash flow-$229.4M-11,360%

Valuation

See full

Market cap$6.53B+152%

Enterprise value$6.28B+162%

P/S11.5×+4.6×

Profitability

See full

Operating margin-139.8%-168pp

Net margin-140.2%-169pp

FCF margin-30.3%—

Returns & leverage

See full

Return on equity-335.8%-377pp

Debt / equity0.1×0.0×

Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedRoyaltiesCurrent.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued royalties (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s accrued royalties (current)?: Mirum Pharmaceuticals, Inc. (MIRM) reported accrued royalties (current) of $15.22M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s accrued royalties (current) changed year-over-year?: Mirum Pharmaceuticals, Inc.'s accrued royalties (current) increased by 50.9% year-over-year, from $10.09M to $15.22M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued royalties (current)?: Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued royalties (current) has grown at a 55.3% compound annual growth rate (CAGR), from $6.72M to $16.21M.